Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Ireland.
Epidemiology and Current Treatment of Neuromyelitis Optica: A Systematic Review.
White matter integrity in polydrug users in relation to attachment and personality: a controlled diffusion tensor imaging study.
Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System.
Relapse May Serve as a Mediator Variable in Longitudinal Outcomes in Multiple Sclerosis.
Co-morbidities increase the risk of disability pension among MS patients: a population-based nationwide cohort study.
Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE.
Phytoestrogens mediated anti-inflammatory effect through suppression of IRF-1 and pSTAT1 expressions in lipopolysaccharide-activated microglia.
Brachial plexus atrophy in chronic inflammatory demyelinating polyradiculoneuropathy.
A previously misdiagnosed cohort of aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder with disease duration of >10 years in multi-ethnic Penang, Malaysia: Clinical features and disease course.
Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice.
Epstein Barr Virus and Mycobacterium avium subsp. paratuberculosis peptides are recognized in sera and cerebrospinal fluid of MS patients.
Neuroimaging and genetic correlates of cognitive dysfunction in multiple sclerosis.
Cluster headache as a first manifestation of multiple sclerosis: case report and literature review.
Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma.
The role of cannabinoids and leptin in neurological diseases.
Cognitive rehabilitation in multiple sclerosis: a randomized controlled trial.
Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families.
Impact of peginterferon beta-1a and disease factors on quality of life in multiple sclerosis.
Attributions and self-efficacy for physical activity in multiple sclerosis.
Correction: Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis.
Evoked potentials are useful for diagnosis of neuromyelitis optica spectrum disorder.
Decision-making impairment in patients with multiple sclerosis: a case-control study.
Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica.
No Geographic Correlation between Lyme Disease and Death Due to 4 Neurodegenerative Disorders, United States, 2001-2010.
Pages
« first
‹ previous
…
687
688
689
690
691
692
693
694
695
…
next ›
last »